<?xml version="1.0" encoding="UTF-8"?>
<ref id="R14">
 <label>14</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Doria</surname>
    <given-names>M.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Tomaselli</surname>
    <given-names>S.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Neri</surname>
    <given-names>F.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Ciafrè</surname>
    <given-names>S. A.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Farace</surname>
    <given-names>M. G.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Michienzi</surname>
    <given-names>A.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Gallo</surname>
    <given-names>A.</given-names>
   </name>
  </person-group>, 
  <article-title>ADAR2 editing enzyme is a novel human immunodeficiency virus-1 proviral factor</article-title>. 
  <source>J. Gen. Virol.</source>
  <volume>92</volume>, 
  <fpage>1228</fpage>–
  <lpage>1232</lpage> (
  <year>2011</year>).
  <pub-id pub-id-type="pmid">21289159</pub-id>
 </mixed-citation>
</ref>
